DECADRON
Live / Registered — Registered — Section 8 accepted (as of 06 Jun 2022)
What this means for you
Registered since 05 Jul 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal was filed 16 Jul 2025 and is awaiting the USPTO's acceptance).
Record
- Serial number
- 86259295
- Registration number
- 4993855
- Mark type
- Word mark
- Filed
- 22 Apr 2014
- Published for opposition
- 09 Sept 2014
- Registered
- 05 Jul 2016
- Next maintenance filing
- §8 & §9 renewal, filed 16 Jul 2025 — awaiting the USPTO's acceptance
Goods and services
- Class 005 — Pharmaceuticals: Hormonal compound for medicinal and pharmaceutical use
Owner
- Pragma Pharmaceuticals, Locust Valley, NY, US
- Pragma Pharmaceuticals, Locust Valley, NY, US
- Pragma Pharmaceuticals, Locust Valley, NY, US
Prosecution history
- 19 Nov 2025 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 03 Nov 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Jul 2025 — TEAS SECTION 8 & 9 RECEIVED
- 05 Jul 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 06 Jun 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 06 Jun 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 06 Jun 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Jan 2022 — TEAS SECTION 8 RECEIVED
- 05 Jul 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 05 Jul 2016 — REGISTERED-PRINCIPAL REGISTER
- 28 May 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 May 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 May 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Apr 2016 — USE AMENDMENT FILED
- 22 Apr 2016 — TEAS STATEMENT OF USE RECEIVED